Sarepta
Sarepta

Sarepta

DR68Ahrefs DR: 68/100. Above median. Measured by Ahrefs. Median 44.Agent34Agent Readiness: 34/100. Below median. Measured by StartupHub.ai. Median 41.Speed42Site Speed: 42/100. Bottom 25%. Measured by Google PageSpeed. Median 62.

Biopharmaceutical company focused on developing RNA-targeted therapies for rare genetic diseases.

Active1162Cambridge, United States

About

Sarepta Therapeutics is a biopharmaceutical company dedicated to discovering, developing, and commercializing RNA-targeted therapeutics for patients with rare genetic diseases. Their primary focus is on Duchenne muscular dystrophy (DMD), a devastating and life-limiting genetic disorder. Sarepta's innovative approach utilizes various RNA-based technologies to address the underlying genetic causes of these diseases.

Key facts

At-a-glance profile data

Website
sarepta.com
Headquarters
Cambridge, United States
Employees
1,162
Total funding
-
Business model
B2B

Tech stack

Detected on sarepta.com and in its job posts, last scanned 1 Sept 2026. Run your own scan

Frontend
jQuery
Backend
Python
CDN
Cloudflare
Hosting
AWS, Google Cloud
Email provider
Mimecast
Email marketing
Mailgun
Hiring platform
Workday
Video / media
Vimeo
Add first review

Frequently asked

How many employees does Sarepta have?

Sarepta has approximately 1,162 people on record.